Literature DB >> 9583599

Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis.

D P Kotler1, T Shimada, G Snow, G Winson, W Chen, M Zhao, Y Inada, F Clayton.   

Abstract

BACKGROUND: Pathogen-negative diarrhea is common in HIV infection and has been associated with clinical symptoms, histopathology, HIV expression, CD4+ lymphocyte depletion, cytokine mRNA expression, and apoptosis of lamina propria mononuclear cells. OBJECTIVES AND METHODS: To examine the short-term (7-day) effects of treatment with combination antiretroviral therapies upon gastrointestinal symptoms and rectal mucosa in 15 HIV-infected subjects.
RESULTS: Treatment was associated with significant decreases in the perception of abdominal bloating and cramps. Similar declines in RNA burden and rises in CD4+ lymphocyte counts were found in blood and mucosa. Treatment was also associated with a fall in the number of lamina propria mononuclear cells undergoing apoptosis by in situ labeling, a change that correlated with the change in mucosal viral burden.
CONCLUSIONS: Peripheral blood and mucosal compartments are equally responsive to effective antiretroviral therapies. The detection of significant changes within 7 days of starting antiviral therapy implies that intestinal dysfunction may be a direct result of local HIV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583599     DOI: 10.1097/00002030-199806000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  18 in total

Review 1.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 2.  Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology.

Authors:  Vincent C Lombardi; Svetlana F Khaiboullina
Journal:  Clin Immunol       Date:  2014-04-24       Impact factor: 3.969

3.  Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy.

Authors:  F Clayton; D P Kotler; S K Kuwada; T Morgan; C Stepan; J Kuang; J Le; J Fantini
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion.

Authors:  Olivier Bourry; Abdelkrim Mannioui; Pierre Sellier; Camille Roucairol; Lucie Durand-Gasselin; Nathalie Dereuddre-Bosquet; Henri Benech; Pierre Roques; Roger Le Grand
Journal:  Retrovirology       Date:  2010-09-26       Impact factor: 4.602

5.  Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2.

Authors:  J J Mattapallil; Z Smit-McBride; P Dailey; S Dandekar
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  HIV and the Gastrointestinal Tract.

Authors:  Nancy F Crum-Cianflone
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2010-09

Review 7.  HIV infection and the gastrointestinal immune system.

Authors:  J M Brenchley; D C Douek
Journal:  Mucosal Immunol       Date:  2008-01       Impact factor: 7.313

8.  Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis.

Authors:  Cynthia L Gay; Myron S Cohen
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

9.  Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy.

Authors:  Hubert Schulbin; Hagen Bode; Hartmut Stocker; Wolfgang Schmidt; Thomas Zippel; Christoph Loddenkemper; Elisabeth Engelmann; Hans-Jörg Epple; Keikawus Arastéh; Martin Zeitz; Reiner Ullrich
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

10.  Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.

Authors:  Julie B Dumond; Y Sunila Reddy; Luigi Troiani; Jose F Rodriguez; Arlene S Bridges; Susan A Fiscus; Geoffrey J Yuen; Myron S Cohen; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.